FindTrial
Sign In

Phase II Study of Z-206

Phase II Study of Z-206

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221898
Enrollment
Unknown
Registered
2012-08-30
Start date
2012-08-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

investigational material(s) Generic name etc : Z-206 INN of investigational material : Mesalazine Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for

Sponsors

Zeria Pharmaceutical Co., Ltd.
Lead Sponsor
Kyowa Hakko Kirin Co., Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with ulcerative colitis

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026